Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study

OBJECTIVES: To evaluate the efficacy and safety of abiraterone acetate plus prednisone (AAP) plus androgen-deprivation therapy (ADT) in Japanese subgroup with newly diagnosed, metastatic hormone-naïve prostate cancer (mHNPC) from Phase 3, randomized, global LATITUDE study. METHODS: Men with mHNPC ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukasawa, Satoshi, Suzuki, Hiroyoshi, Kawaguchi, Kazushiro, Noguchi, Hidehisa, Enjo, Kentaro, Tran, Namphuong, Todd, Mary, Fizazi, Karim, Matsubara, Nobuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214222/
https://www.ncbi.nlm.nih.gov/pubmed/30371895
http://dx.doi.org/10.1093/jjco/hyy129

Ejemplares similares

Ejemplares similares